The specialty of Neurology is concerned with the diagnosis and treatment of patients with disorders of the central nervous system (brain and spinal cord) and the peripheral nervous system (nerves) and muscle.
Some Neurological conditions include;
The Neurology Team at Bon Secours Hospital Tralee comprises of:
Treatment-
Many of our MS patients are worried about their illness in the context of COVID-19. At present the guidelines are to stay on your medication. The risk of stopping medication will result in the deterioration of your MS so the balance of risk is that you should continue your treatment.
We are advised that we shouldn’t commence any new medication such as Ocrelizumab, Mavenclad or Lemtrada and it is has also been advised that a second dose of Mavenclad should not be given for now.
The advice for everyone from the HSE at this time is for stringent hand washing and social distancing.
If you had a cough, shortness of breath and fever, you should contact your GP and follow their protocols.
Dr Helena Moore,
Consultant Neurologist & Clinical Director,
Bon Secours Hospital Tralee.
Alzheimer Society of Ireland - T: 1800 341341
Brainwave Irish Epilepsy Association -T: 021 4274474
Irish Carers Association -T: 1800 240724
Migraine Association of Ireland -T: 1850 200387
Multiple Sclerosis Society Ireland -T: 1850 233233
Irish Motor Neurone Disease Association -T: 1800 403403
Parkinson’s Disease Association -T: 1800 359359
Dr Moore is a Consultant Neurologist and Clinical Director at the Bon Secours Hospital Tralee. Dr Moore graduated from University College Galway in 1988. Dr Moore carried out her specialist training in both Ireland and England, completing training schemes in Cork University Hospital and the Radcliffe Infirmary, Oxford. Dr Moore has participated in numerous audits and publications. Dr Moore’s teaching experience includes; being appointed as an Associate Tutor at the Royal College of Physicians and lecturing in Medicine at the Unversity College Dublin.
Dr Moore has a Specialist interest in Dystonia, Parkinson’s Disease and Multiple Sclerosis.